Oncology Diagnostic Articles & Analysis
35 news found
“Our collaboration with AstraZeneca has the potential to dramatically accelerate global access to liquid biopsy testing, especially in underserved populations, which in turn could contribute to reshaping diagnostics, treatment, and monitoring of cancer cases throughout the world. ...
To facilitate these services, the company has established one of the largest and most comprehensive databases of metabolic health profiles across healthy and diseased individuals covering multiple age and gender groups as well as specific diseases in neurology, oncology, and inflammation. Lifespin, a deep data company that maps human health based on snapshots of metabolic ...
The increased importance of gene fusions in oncology is driving demand from diagnostic laboratories for scalable analytical solutions. ...
A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography (‘OCT’) technology, which can transform patient’s treatment and care of basal cell carcinomas (BCC). It was concluded that OCT-guided diagnosis, when compared to a ...
Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research Reports Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today ...
Research, production and marketing are the strengths of our company, and Smiling and Gesanbiotecno projects are an excellent opportunity to enhance the concept of integration between man, environment and technology. In Gesan, R&D department is a fundamental asset for the company’s business and all activities are constantly oriented towards the production and distribution of innovative ...
“We are delighted to transfer our OncoDEEP technology to further enhance Synlab in the field of molecular diagnostics for clinical oncology,” stated Bernard Courtieu, CEO of OncoDNA. ...
PathPresenter, a pioneer in the development of digital pathology software, and 4D Path Inc., developer of a pan-cancer diagnostic and precision oncology platform enabling AI-based biomarker typing and prognostication from H&E images, are announcing today a global partnership to distribute 4D Q-plasia OncoReader Breast within PathPresenter’s new Clinical ...
Feeney’s expertise building sales and market access teams across specialty areas, including liquid biopsy, oncology, and women's health, will play a critical role in advancing the commercial strategy and development of 4D Path’s cancer diagnostic and precision oncology platform technology. ...
--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO® and other therapies in Loxo Oncology at Lilly’s pipeline. ...
The scope of the Positron/Neusoft agreement is to further develop the utilization of its PET/CT technology and services for nuclear cardiology while expanding into the field of oncology imaging diagnostics and clinical services. The U.S. is the largest total addressable market for both cardiology and oncology fields and will continue to be ...
–(BUSINESS WIRE)– GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the completion of its Piedmont Study, conducted in collaboration with Atrium Health Levine Cancer Institute. ...
SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in Middle Eastern markets. ...
This is an important addition to our service and product portfolio,” explains Damla Bozkulak, Head of Marketing and Business Development at Gen Era Diagnostics. Gen Era Diagnostics is one of the leading product and service providers in the field of molecular diagnostics in Turkey. ...
It involves ribonucleic acid (RNA)-based diagnostics and companion diagnostics development, combining GeneCentric’s extensive pipeline of predictive response gene signatures with Labcorp’s decades-long leadership in bringing new tests to market. ...
4D Path, creator of a patented computer-aided pan-cancer diagnostic and precision oncology platform, is pleased to announce that Dr. ...
Bastiaan van der Baan, MSc, is currently Chief Clinical and Business Officer at oncology diagnostics test provider Agendia, where he has helped building up the company’s global clinical and commercial infrastructure. ...
4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Dr. ...
4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the University of Leeds in the UK through 2027, the two organizations announced today. ...
4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Jennifer Levin Carter, MD, MPH, MBA, has joined the company’s distinguished advisory board. ...